Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine

doi:10.4252/wjsc.v3.i11.96

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4080)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

307

HTML

3477

Figures (1-2)

185

Tables (1-1)

111

Sum=4080

Nov 26, 2011 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (36)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Stem Cells. Nov 26, 2011; 3(11): 96-103
Published online Nov 26, 2011. doi: 10.4252/wjsc.v3.i11.96

Table 1 Mesenchymal stem cells as cellular vehicles for targeting cancer

Anticancer agent	Anticancer mechanism	Tumor model	Route of MSC admi-nistration	Species: MSC/tumor/host	Ref.
CX3CL1	Immunostimulatory	Lung	iv	Mouse/mouse/mouse	[40]
CD	Prodrug converting	Prostate	sc/iv	Human/human/mouse	[41]
		Colon	sc/iv	Human/human/mouse	[14]
HSV-tk		Glioma	it	Rat/rat/rat	[42]
		Pancreas	iv	Mouse/mouse/mouse	[28]
IFNα	Immunostimulatory and apoptosis indcing	Melanoma	iv	Mouse/mouse/mouse	[43]
		Glioma	it/ic	Mouse/mouse/mouse	[44]
IFNβ		Breast	sc/iv	Human/human/mouse	[29,45]
		Pancreas	ip	Human/human/mouse	[27]
IL2		Glioma	it/ic	Rat/rat/rat	[17]
IL7	Immunostimulatory	Glioma	it	Rat/rat/rat	[46]
IL12	Activates cytotoxic lymphocyte and NK cells	Melanoma	iv	Mouse/mouse/mouse	[47]
		Hepatoma	iv	Mouse/mouse/mouse	[47]
		Breast	iv	Mouse/mouse/mouse	[47]
IL18	Immunostimulatory	Glioma	it	Rat/rat/rat	[48]
NK4	Inhibits angiogenesis	Colon	iv	Mouse/mouse/mouse	[49]
TRAIL	Induces apoptosis	Glioma	it	Human/human/mouse	[20]
		Glioma	ic	Human/human/mouse	[50]
		Glioma	iv	Human/human/mouse	[22,51]
		Lung	iv	Human/human/mouse	[52]
		Breast, lung	sc/iv	Human/human/mouse	[53]
		Colon	sc	Human/human/mouse	[54,55]
		Pancreas	iv	Human/human/mouse	[56]

CD: Cytosine deaminase; CX3CL1: Chemokine fractalkine; HSV-tk: Herpes simplex virus-thymidine kinase; ic: Intracerebral; IFN: Interferon; IL: Interleukin; ip: Intraperitoneal; it: Intratumoral; iv: Intravenous; NK: Natural killer; sc: Subcutaneous; TRAIL: Tumor necrosis factor-related apoptosis-inducing ligand.

Citation: Sun XY, Nong J, Qin K, Warnock GL, Dai LJ. Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine. World J Stem Cells 2011; 3(11): 96-103
URL: https://www.wjgnet.com/1948-0210/full/v3/i11/96.htm
DOI: https://dx.doi.org/10.4252/wjsc.v3.i11.96